News

Surgery Partners, Inc. Reports Impressive Growth and 2025 Goals

Surgery Partners, Inc. Reports Impressive Growth and 2025 Goals

Surgery Partners, Inc. Financial Performance Review

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent owner and operator of outpatient surgical facilities, recently released its financial results for the fourth quarter and the full year of 2024. The company showcased impressive growth, continuing its trend of expanding operational success.

Highlights from 2024 Results

During the fourth quarter, Surgery Partners experienced a revenue increase of 17.5%, amounting to an impressive $864.4 million compared to the previous year. For the entire year, revenue rose by 13.5%, totaling $3.1 billion, underlining the sustained demand for its surgical services.

The same-facility revenue also followed suit, climbing 5.6% in Q4 and 8.0% across the year. This increase reflects Surgery Partners' ability to attract more cases, as evidenced by a 5.1% rise in same-facility cases during the fourth quarter.

Long-Term Adjustments and Fiscal Management

Despite the robust revenue growth, the company reported a net loss of $108.5 million in Q4 and $168.1 million for the full year. This loss was impacted by a non-cash valuation allowance against deferred tax assets, resulting from technical accounting mandates. Surgery Partners plans to offset federal income taxes through its net operating loss carryforwards until 2029, which positions the company well for future profitability.

Adjusted EBITDA and Margin Growth

Adjusted EBITDA for the fourth quarter surged by 15.1% to $163.8 million, escalating to a total of $508.2 million for the year, reflecting an adjustment margin growth by 30 basis points to 16.3%. This improvement indicates a positive trajectory in operational efficiency and profitability.

Looking Ahead: Guidance for 2025

Eric Evans, the Chief Executive Officer, expressed optimism regarding the company’s growth momentum. For 2025, Surgery Partners projects revenues between $3.30 billion and $3.45 billion, alongside an anticipated Adjusted EBITDA in the range of $555 million to $565 million. This forecast is predicated on strategic expansions and operational enhancements intended to deliver exceptional value to both patients and healthcare plans.

Strategic Initiatives and Facility Expansions

Throughout 2024, Surgery Partners invested nearly $400 million on acquisitions and opened eight new facilities. These initiatives are pivotal as the company aims to broaden its network, ensuring high-quality surgical care across multiple states. The operational advancements underscore the company’s commitment to enriching patient experiences and enhancing service accessibility.

Strong Liquidity Position

Surgery Partners ended the year with a strong liquidity position, boasting over $770 million in liquid assets, empowering the company to pursue further mergers and acquisitions without relying on external capital markets. This robust financial footing instills confidence in Surgery Partners' ability to navigate the evolving healthcare landscape effectively.

Conclusion: A Promising Future

As Surgery Partners continues to evolve and expand, its focus remains on leveraging existing strengths to capitalize on new growth opportunities in the outpatient surgical sector. The company's strategic vision and unwavering commitment to operational excellence position it favorably for sustained success in the coming years. Investors and stakeholders alike can look forward to an exciting journey ahead as Surgery Partners, Inc. embarks on its ambitious 2025 strategy.

Frequently Asked Questions

What are the financial highlights for Surgery Partners, Inc. in 2024?

In 2024, Surgery Partners reported a 17.5% revenue increase in Q4 and a total annual revenue of $3.1 billion, reflecting strong demand for surgical services.

How did Surgery Partners manage its losses?

The reported net losses stemmed mainly from a non-cash valuation allowance against deferred tax assets, with expectations of offsetting federal taxes until 2029.

What is the outlook for Surgery Partners in 2025?

The company projects revenues between $3.30 billion and $3.45 billion, with Adjusted EBITDA expected to be between $555 million and $565 million.

How much was invested in acquisitions by Surgery Partners in 2024?

Surgery Partners deployed nearly $400 million towards acquisitions to expand its network and service offerings.

What does the liquidity position of Surgery Partners look like?

As of year-end 2024, Surgery Partners maintained over $770 million in liquidity, allowing continued investment in growth without external financing.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delta Marks 19 Years at COP With Bold New Initiatives

Updated Category News Views 62

Delta's Commitment to Global Sustainability Delta's name pops up yet again at the United Nations Climate Change Conference (COP31) in Antalya, Turkey, marking the company's 19th consecutive year of participation. They're mounting efforts to hit that "35×35" target, aiming for 35% electrification by 2035. This isn't just fluff and rhetoric—it’s Delta taking the lead...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 164

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Lululemon Faces Lawsuit Over Securities Violations Concerns

Updated Category News Views 0

Lululemon in Legal Crosshairs So, here's the scoop that's rocking the activewear world. Lululemon athletica inc. (NASDAQ: LULU) is finding itself in hot legal water. The DJS Law Group is sounding the alarm for investors following a securities violation lawsuit slapped on the company. We're talking about some heavy allegations of misleading maneuvers, with accusations...

Continue Reading
TURNSON: A New Twist in the Drinking Game Arena

Updated Category News Views 0

TURNSON Raises the Bar for Social Fun When was the last time a new drinking game actually turned heads? Well, meet TURNSON, the fresh contender coming out of a tiny town in Louisiana. Thanks to a couple of inventive minds, this game aims to redefine how adults bond at parties. It's got the ingredients to stir up some excitement at social gatherings, parties, and wherever...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 417

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 23

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
Nutex Health Scores Top Workplace Honor in 2026

Updated Category News Views 95

Nutex Health: Accolades and Aspirations Nutex Health just snagged something pretty noteworthy: They've been crowned a 2026 Houston Top Workplace by the Houston Chronicle. Now, before you start throwing confetti, let's chew on what this really means. It's no small potatoes, folks. We're talking employee respect and satisfaction measured by Energage’s surveys. It's proof...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 214

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
California Credit Union's Toy Drive Brings Holiday Cheer

Updated Category News Views 0

California Credit Union Joins Forces for Holiday Toy Drive Alright, folks, here’s a story with a feel-good spin straight out of Glendale. California Credit Union is at it again, teaming up with the Los Angeles Boys & Girls Club to sprinkle some holiday magic on local kiddos and their families. Now, it’s the sixth year straight they’ve pulled off this toy drive...

Continue Reading
Valmet Expands Board Maker Deal in Asia With New Line

Updated Category News Views 223

If there's one thing Valmet understands, it's the beauty of a longstanding business relationship. On November 9, 2026, the Finnish powerhouse announced another feather in its cap—a new board making line order from a major client in Asia. This deal ain't just another tick in the order books. No, sir, it's about prowess and power in the paper game. Building on Existing...

Continue Reading

Top 5 Most Recently Viewed Articles

Sulliden Mining Capital's Annual Meeting Results Unveiled

Updated Category News Views 159

Sulliden Mining Capital's Annual Meeting Results Unveiled On June 30, 2025, Sulliden Mining Capital Inc. (TSX: SMC) held its Annual and Special Meeting of Shareholders. This event followed the guidelines established by the Toronto Stock Exchange. During the meeting, shareholders engaged in an essential process—electing nominees presented in the management information...

Continue Reading
Ascential Medical's Dynamic Leadership Changes for Growth

Updated Category News Views 348

Leadership Changes at Ascential Medical & Life Sciences Ellen Scipta and Chris Cowen are stepping into pivotal roles as CFO and CCO at Ascential Medical & Life Sciences, while Todd Martensen transitions to the role of CSO. These changes reflect the company's commitment to innovation and strategic growth. Introducing Ellen Scipta: New Chief Financial Officer Ellen Scipta...

Continue Reading
Investors Target Xerox Holdings for Securities Class Action

Updated Category News Views 201

Legal Investigation of Xerox Holdings Corporation Faruqi & Faruqi, LLP, a highly regarded national securities law firm, is currently investigating potential claims involving Xerox Holdings Corporation (NASDAQ: XRX). Investors who have suffered significant financial losses are encouraged to reach out to discuss options available to them. Investor Losses and Legal Options...

Continue Reading
Understanding the Risks of Sharing Back-to-School Photos

Updated Category News Views 240

Understanding the Risks of Sharing Back-to-School Photos As families across the nation prepare for a new school year, there’s an important reminder from experienced investigator and child advocate, Moses Castillo. Before sharing those back-to-school photos on social media, it's crucial to consider the potential dangers associated with such posts. The Hidden Dangers of...

Continue Reading
Intel's Journey: Overcoming Two Decades of Market Struggles

Updated Category News Views 111

Intel's Long Road to Recovery Intel has faced significant challenges over the past two decades. Its stock performance has been lackluster, rising only 2% compared to the NASDAQ 100, which has surged over 1,200%. This stark contrast raises questions about Intel's strategic decisions and future direction. Intel's leadership has stumbled in crucial areas that have allowed...

Continue Reading